Litigation Details for Par Pharmaceutical Inc v. Pfizer Inc (S.D.N.Y. 2019)
✉ Email this page to a colleague
Par Pharmaceutical Inc v. Pfizer Inc (S.D.N.Y. 2019)
| Docket | ⤷ Sign Up | Date Filed | 2019-01-21 |
| Court | District Court, S.D. New York | Date Terminated | 2019-03-15 |
| Cause | 28:2201dj Declaratory Judgment | Assigned To | William H. Pauley III |
| Jury Demand | None | Referred To | |
| Parties | PAR PHARMACEUTICAL INC | ||
| Patents | 6,890,927; 7,265,119 | ||
| Attorneys | David Hugh Silverstein | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Par Pharmaceutical Inc v. Pfizer Inc
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Par Pharmaceutical Inc v. Pfizer Inc (S.D.N.Y. 2019)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2019-01-21 | 1 | claim of U.S. Patent Nos. 6,890,927 (the “’927 patent”) and 7,265,119 (the “’119 patent) (collectively…Non-Infringement of U.S. Patent Nos. 6,890,927 and 7,265,119 34. Par realleges… of U.S. Patent Nos. 6,890,927 and 7,265,119 39. Par realleges…resolution of patent disputes by authorizing a patent owner to sue an ANDA applicant for patent infringement…collectively, “patents-in-suit”). Par brings this suit to obtain patent certainty under 21 U.S.C. § 355(j)(5)( | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
